Century Therapeutics, Inc.
IPSC- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001850119
In the last 90 days, Century Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 100 institutions reported holding it in 13F filings for Q2 2026, worth $387.0M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Century Therapeutics, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 67 | 61 | −6 |
| Shares | 23.1M | 40.1M | +17.0M (+73.6%) |
| Value | $96.6M | $102.3M | +$5.70M (+5.9%) |
New holders (7)
Institutions that held Century Therapeutics, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 5,410,361 | $13.8M | 1.51% |
| Adage Capital Partners GP, L.L.C. | 1,322,751 | $3.37M | 0.01% |
| Syncona Portfolio Ltd | 1,000,771 | $2.55M | 2.97% |
| Corebridge Financial, Inc. | 24,683 | $62.9K | 0.00% |
| Voya Investment Management LLC | 17,437 | $44.5K | 0.00% |
| Price T Rowe Associates Inc | 14,882 | $38.0K | 0.00% |
| Mirae Asset Global ETFs Holdings Ltd. | 11,389 | $29.0K | 0.00% |
Sold out (13)
Institutions that held Century Therapeutics, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Avidity Partners Management LP | 1,221,555 | $5.11M |
| Schonfeld Strategic Advisors LLC | 93,085 | $389.1K |
| Jump Financial, LLC | 22,330 | $93.3K |
| Cubist Systematic Strategies, LLC | 18,907 | $79.0K |
| Occudo Quantitative Strategies LP | 13,562 | $56.7K |
| American International Group, Inc. | 11,543 | $48.3K |
| Abel Hall, LLC | 10,071 | $42.1K |
| Mirae Asset Global Investments Co., Ltd. | 11,130 | $38.5K |
| Catalyst Funds Management Pty Ltd | 6,900 | $28.8K |
| Point72 (DIFC) Ltd | 6,435 | $26.9K |
| Comerica Bank | 2,946 | $12.3K |
| Qube Research & Technologies Ltd | 334 | $1.40K |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 6 | $25 |